CE stock · ERNA stock

CE vs ERNA

Celanese Corporation (CE) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.

Celanese Corporation (CE) is a chemicals company listed on US.

Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.

Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.

Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.

CE currently screens at market cap $5.92B. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.

Not investment advice. Open the CE and ERNA stock pages for the full models.

Not investment advice.

Popular Stock Comparisons